Page last updated: 2024-08-25
magnoflorine and Osteosarcoma
magnoflorine has been researched along with Osteosarcoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Pei, Y; Qiu, E; Shang, G; Wang, W; Wang, Y; Zhang, X | 1 |
Other Studies
1 other study(ies) available for magnoflorine and Osteosarcoma
Article | Year |
---|---|
Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
Topics: Aporphines; Cell Line, Tumor; Cell Proliferation; Cisplatin; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; MicroRNAs; Neoplasm Invasiveness; NF-kappa B; Osteosarcoma; Phenotype; Signal Transduction; Up-Regulation | 2020 |